News headlines Eli Lilly is positioned as a strong player in the obesity treatment market, bolstered by significant revenue growth and a robust pipeline. The recent FDA approval of rival Novo ...
The latest price target for Eli Lilly (NYSE:LLY) was reported by B of A Securities on December 15, 2025. The analyst firm set a price target for $1268.00 expecting LLY to rise to within 12 months (a ...
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback